Construction and Validation of New Nomograms to Predict Risk and Prognostic Factors of Breast Cancer Bone Metastasis in Asian Females: A Population-Based Retrospective Study

References

• Fan L, Strasser-Weippl K, Li JJ, et al. Breast cancer in China. Lancet Oncol. 2014;15(7):e279–e289. doi:10.1016/S1470-2045(13)70567-9
   PubMed Web of Science ®Google Scholar
• Liang Y, Zhang H, Song X, et al. Metastatic heterogeneity of breast cancer: molecular mechanism and potential therapeutic targets. Semin Cancer Biol. 2020;60:14–27. doi:10.1016/j.semcancer.2019.08.012
   PubMed Web of Science ®Google Scholar
• Shemanko CS, Cong Y, Forsyth A. What is breast in the bone? Int J Mol Sci. 2016;17(10):1764. doi:10.3390/ijms17101764
   PubMed Web of Science ®Google Scholar
• Coleman RE, Croucher PI, Padhani AR, et al. Bone metastases. Nat Rev Dis Primers. 2020;6(1):83. doi:10.1038/s41572-020-00216-3
   PubMed Web of Science ®Google Scholar
• Bidwell BN, Slaney CY, Withana NP, et al. Silencing of Irf7 pathways in breast cancer cells promotes bone metastasis through immune escape. Nat Med. 2012;18(8):1224–1231. doi:10.1038/nm.2830
   PubMed Web of Science ®Google Scholar
• Jiang P, Gao W, Ma T, et al. CD137 promotes bone metastasis of breast cancer by enhancing the migration and osteoclast differentiation of monocytes/macrophages. Theranostics. 2019;9(10):2950–2966. doi:10.7150/thno.29617
   PubMed Web of Science ®Google Scholar
• Yang M, Liu C, Yu X. Skeletal-related adverse events during bone metastasis of breast cancer: current status. Discov Med. 2019;27(149):211–220.
   PubMed Web of Science ®Google Scholar
• Harbeck N, Gnant M. Breast cancer. Lancet. 2017;389(10074):1134–1150. doi:10.1016/S0140-6736(16)31891-8
   PubMed Web of Science ®Google Scholar
• Liu D, Wu J, Lin C, et al. Breast subtypes and prognosis of breast cancer patients with initial bone metastasis: a Population-Based Study. Front Oncol. 2020;10:580112. doi:10.3389/fonc.2020.580112
   PubMed Web of Science ®Google Scholar
• Li X, Zhang X, Liu J, et al. Prognostic factors and survival according to tumour subtype in women presenting with breast cancer bone metastases at initial diagnosis: a SEER-based study. BMC Cancer. 2020;20(1):1102. doi:10.1186/s12885-020-07593-8
   PubMed Web of Science ®Google Scholar
• Balachandran VP, Gonen M, Smith JJ, et al. Nomograms in oncology: more than meets the eye. Lancet Oncol. 2015;16(4):e173–e180. doi:10.1016/S1470-2045(14)71116-7
   PubMed Web of Science ®Google Scholar
• Liu X, Zhang D, Liu Z, et al. Deep learning radiomics-based prediction of distant metastasis in patients with locally advanced rectal cancer after neoadjuvant chemoradiotherapy: a multicentre study. EBioMedicine. 2021;69:103442. doi:10.1016/j.ebiom.2021.103442
   PubMed Web of Science ®Google Scholar
• Dong Y, Que L, Jia Q, et al. Predicting reintervention after thoracic endovascular aortic repair of Stanford type B aortic dissection using machine learning. Eur Radiol. 2021. doi:10.1007/s00330-021-07849-2
   Web of Science ®Google Scholar
• Zhao W, Wu L, Zhao A, et al. A nomogram for predicting survival in patients with de novo metastatic breast cancer: a population-based study. BMC Cancer. 2020;20(1):982. doi:10.1186/s12885-020-07449-1
   PubMed Web of Science ®Google Scholar
• Cronin KA, Ries LA, Edwards BK. The Surveillance, Epidemiology, and End Results (SEER) program of the national cancer institute. Cancer. 2014;120(Suppl 23):3755–3757. doi:10.1002/cncr.29049
   PubMed Web of Science ®Google Scholar
• Liu Y, Wu L, Ao H, et al. Prognostic implications of autophagy-associated gene signatures in non-small cell lung cancer. Aging. 2019;11(23):11440–11462. doi:10.18632/aging.102544
   PubMedGoogle Scholar
• Harrell FE Jr, Lee KL, Mark DB. Multivariable prognostic models: issues in developing models, evaluating assumptions and adequacy, and measuring and reducing errors. Stat Med. 1996;15(4):361–387. doi:10.1002/(SICI)1097-0258(19960229)15:4<361::AID-SIM168>3.0.CO;2-4
   PubMed Web of Science ®Google Scholar
• Xu D, Zhang K, Li M, et al. Prognostic nomogram for resected pancreatic adenocarcinoma: a TRIPOD-compliant retrospective long-term survival analysis. World J Surg. 2020;44(4):1260–1269. doi:10.1007/s00268-019-05325-z
   PubMed Web of Science ®Google Scholar
• Moezian GSA, Javadinia SA, Sales SS, et al. Oral silymarin formulation efficacy in management of AC-T protocol induced hepatotoxicity in breast cancer patients: a randomized, triple blind, placebo-controlled clinical trial. J Oncol Pharm Pract. 2021:10781552211006182. doi:10.1177/10781552211006182
   Web of Science ®Google Scholar
• Salek R, Dehghani M, Mohajeri SA, et al. Amelioration of anxiety, depression, and chemotherapy related toxicity after crocin administration during chemotherapy of breast cancer: a double blind, randomized clinical trial. Phytother Res. 2021;35(9):5143–5153. doi:10.1002/ptr.7180
   PubMed Web of Science ®Google Scholar
• Engel J, Weichert W, Jung A, et al. Lymph node infiltration, parallel metastasis and treatment success in breast cancer. Breast. 2019;48:1–6. doi:10.1016/j.breast.2019.07.008
   PubMed Web of Science ®Google Scholar
• Tosello G, Torloni MR, Mota BS, et al. Breast surgery for metastatic breast cancer. Cochrane Database Syst Rev. 2018;3(3):Cd011276. doi:10.1002/14651858.CD011276.pub2
   PubMed Web of Science ®Google Scholar
• Li X, Yang J, Peng L, et al. Triple-negative breast cancer has worse overall survival and cause-specific survival than non-triple-negative breast cancer. Breast Cancer Res Treat. 2017;161(2):279–287. doi:10.1007/s10549-016-4059-6
   PubMed Web of Science ®Google Scholar
• Zhang H, Zhu W, Biskup E, et al. Incidence, risk factors and prognostic characteristics of bone metastases and skeletal-related events (SREs) in breast cancer patients: a systematic review of the real world data. J Bone Oncol. 2018;11:38–50. doi:10.1016/j.jbo.2018.01.004
   PubMed Web of Science ®Google Scholar
• Sakhuja S, Deveaux A, Wilson LE, et al. Patterns of de-novo metastasis and breast cancer-specific mortality by race and molecular subtype in the SEER population-based dataset. Breast Cancer Res Treat. 2021;186(2):509–518. doi:10.1007/s10549-020-06007-4
   PubMed Web of Science ®Google Scholar
• Gao T, Shao F. Risk factors and prognostic factors for inflammatory breast cancer with bone metastasis: a population-based study. J Orthop Surg. 2021;29(2):23094990211000144. doi:10.1177/23094990211000144
   Web of Science ®Google Scholar
• Goupille C, Frank PG, Arbion F, et al. Low levels of omega-3 long-chain polyunsaturated fatty acids are associated with bone metastasis formation in premenopausal women with breast cancer: a Retrospective Study. Nutrients. 2020;12(12):3832. doi:10.3390/nu12123832
   PubMed Web of Science ®Google Scholar
• Gong Y, Zhang J, Ji P, et al. Incidence proportions and prognosis of breast cancer patients with bone metastases at initial diagnosis. Cancer Med. 2018;7(8):4156–4169. doi:10.1002/cam4.1668
   PubMed Web of Science ®Google Scholar
• Purushotham A, Shamil E, Cariati M, et al. Age at diagnosis and distant metastasis in breast cancer–a surprising inverse relationship. Eur J Cancer. 2014;50(10):1697–1705. doi:10.1016/j.ejca.2014.04.002
   PubMed Web of Science ®Google Scholar
• Arciero CA, Guo Y, Jiang R, et al. ER(+)/HER2(+) breast cancer has different metastatic patterns and better survival than ER(-)/HER2(+) breast cancer. Clin Breast Cancer. 2019;19(4):236–245. doi:10.1016/j.clbc.2019.02.001
   PubMed Web of Science ®Google Scholar
• Hayashi N, Iwamoto T, Qi Y, et al. Bone metastasis-related signaling pathways in breast cancers stratified by estrogen receptor status. J Cancer. 2017;8(6):1045–1052. doi:10.7150/jca.13690
   PubMed Web of Science ®Google Scholar
• Allocca G, Hughes R, Wang N, et al. The bone metastasis niche in breast cancer-potential overlap with the haematopoietic stem cell niche in vivo. J Bone Oncol. 2019;17:100244. doi:10.1016/j.jbo.2019.100244
   PubMed Web of Science ®Google Scholar
• Zhou X, Zheng Z, Li Y, et al. The clinical features and prognosis of patients with mucinous breast carcinoma compared with those with infiltrating ductal carcinoma: a population-based study. BMC Cancer. 2021;21(1):536. doi:10.1186/s12885-021-08262-0
   PubMed Web of Science ®Google Scholar
• Huang Z, Zhou X, Tong Y, et al. Surgery for primary tumor benefits survival for breast cancer patients with bone metastases: a large cohort retrospective study. BMC Cancer. 2021;21(1):222. doi:10.1186/s12885-021-07964-9
   PubMed Web of Science ®Google Scholar
• Erić I, Petek erić A, Kristek J, et al. Breast cancer in young women: pathologic and immunohistochemical features. Acta Clin Croat. 2018;57(3):497–502. doi:10.20471/acc.2018.57.03.13
   PubMed Web of Science ®Google Scholar
• Thomas M, Kelly ED, Abraham J, et al. Invasive lobular breast cancer: a review of pathogenesis, diagnosis, management, and future directions of early stage disease. Semin Oncol. 2019;46(2):121–132. doi:10.1053/j.seminoncol.2019.03.002
   PubMed Web of Science ®Google Scholar